SCHULTZ, JOHAN,VAGBERG, JAN,OLSSON, ELISABETH,FARNEGARDH, KATARINA,JONSSON, MATTIAS,HAMMER, KRISTIN,KRUGER, LARS
申请号:
CA2984971
公开号:
CA2984971A1
申请日:
2015.05.11
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
A compound of formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compound. The compound is useful in therapy, for the treatment of disorders mediated by HDAC6, such as autoimmune disorders, neurodegenerative disorders and hyperproliferative disorders, such as cancer.